87 related articles for article (PubMed ID: 15829299)
41. CD4-IgG binding threshold for inactivation of human immunodeficiency virus type 1.
Berkower I; Mostowski H; Bull TE; Murphy D
J Infect Dis; 1996 Apr; 173(4):863-9. PubMed ID: 8603964
[TBL] [Abstract][Full Text] [Related]
42. Binding of anti-CD4 monoclonal antibody to D1 domain (CR1, CR2 epitopes) of CD4 molecule.
Koubek K
Folia Biol (Praha); 1999; 45(2):67-9. PubMed ID: 10732737
[No Abstract] [Full Text] [Related]
43. Expression and characterization of human CD4:immunoglobulin fusion proteins.
Zettlmeissl G; Gregersen JP; Duport JM; Mehdi S; Reiner G; Seed B
DNA Cell Biol; 1990 Jun; 9(5):347-53. PubMed ID: 2196903
[TBL] [Abstract][Full Text] [Related]
44. Disulfide exchange in domain 2 of CD4 is required for entry of HIV-1.
Matthias LJ; Yam PT; Jiang XM; Vandegraaff N; Li P; Poumbourios P; Donoghue N; Hogg PJ
Nat Immunol; 2002 Aug; 3(8):727-32. PubMed ID: 12089508
[TBL] [Abstract][Full Text] [Related]
45. Antibodies reactive with C-terminus of the second conserved region of HIV-1gp120 as possible prognostic marker and therapeutic agent for HIV disease.
Veljkovic N; Branch DR; Metlas R; Prljic J; Manfredi R; Stringer WW; Veljkovic V
J Clin Virol; 2004 Dec; 31 Suppl 1():S39-44. PubMed ID: 15567092
[TBL] [Abstract][Full Text] [Related]
46. Improving the CH1-CK heterodimerization and pharmacokinetics of 4Dm2m, a novel potent CD4-antibody fusion protein against HIV-1.
Chen W; Bardhi A; Feng Y; Wang Y; Qi Q; Li W; Zhu Z; Dyba MA; Ying T; Jiang S; Goldstein H; Dimitrov DS
MAbs; 2016; 8(4):761-74. PubMed ID: 26963639
[TBL] [Abstract][Full Text] [Related]
47. Molecular makeup of HIV-1 envelope protein.
Veljkovic V; Veljkovic N; Metlas R
Int Rev Immunol; 2004; 23(5-6):383-411. PubMed ID: 15370272
[TBL] [Abstract][Full Text] [Related]
48. [Cloning and expression of the CD4 receptor gene from human T-lymphocytes in Escherichia coli cells].
Zverev VV; Shakhov AN; Nedospasov SA; Pugach AV; Sidorov AV; Maliushova VV; Andzhaparidze OG
Mol Gen Mikrobiol Virusol; 1991 Jan; (1):16-8. PubMed ID: 2023597
[TBL] [Abstract][Full Text] [Related]
49. Biological and pharmacokinetic properties of a novel immunoglobulin-CD4 fusion protein.
Lyczak JB; Morrison SL
Arch Virol; 1994; 139(1-2):189-96. PubMed ID: 7826209
[TBL] [Abstract][Full Text] [Related]
50. A novel TNFalpha antagonizing peptide-Fc fusion protein designed based on CDRs of TNFalpha neutralizing monoclonal antibody.
Qin W; Feng J; Zhang W; Li Y; Shen B
Biochem Biophys Res Commun; 2004 Sep; 322(3):1024-8. PubMed ID: 15336567
[TBL] [Abstract][Full Text] [Related]
51. Mouse/human chimeric anti-HIV-1 gp120 antibody to the principal neutralizing determinant: tolerability and pharmacokinetics in cynomolgus monkeys, Macaca fascicularis.
Liou RS; Fung MS; Zühlke U; Gudat F; McKinney S; Gordon W; Bee W; Botta L; Gygax D; Chang TW
Biotherapy; 1992; 5(4):291-9. PubMed ID: 1283953
[TBL] [Abstract][Full Text] [Related]
52. Full Length Single Chain Fc Protein (FLSC IgG1) as a Potent Antiviral Therapy Candidate: Implications for In Vivo Studies.
Latinovic OS; Medina-Moreno S; Schneider K; Gohain N; Zapata J; Pazgier M; Reitz M; Bryant J; Redfield RR
AIDS Res Hum Retroviruses; 2016 Feb; 32(2):178-86. PubMed ID: 26059995
[TBL] [Abstract][Full Text] [Related]
53. Chimeric human-simian anti-CD4 antibodies form crystalline high symmetry particles.
Kuznetsov YG; Day J; Newman R; McPherson A
J Struct Biol; 2000 Aug; 131(2):108-15. PubMed ID: 11042081
[TBL] [Abstract][Full Text] [Related]
54. Human-murine chimeric CD4 monoclonal antibodies. A modern panacea for autoimmune disease?
Riethmüller G; Deusch K; Sanders ME; Dalesandro MR; Kiefersauer S; Reiter C; Rieber EP
Immunol Ser; 1993; 59():261-9. PubMed ID: 8461391
[No Abstract] [Full Text] [Related]
55. A CD 4: immunoglobulin fusion protein with antiviral effects against HIV.
Gregersen JP; Mehdi S; Gelderblom H; Zettlmeissl G
Arch Virol; 1990; 111(1-2):29-43. PubMed ID: 2109590
[TBL] [Abstract][Full Text] [Related]
56. Homogeneous sandwich immunoassay based on the enzymatic complementation induced by single-chain Fv fragments.
Komiya N; Ueda H; Ohiro Y; Nagamune T
Anal Biochem; 2004 Apr; 327(2):241-6. PubMed ID: 15051541
[TBL] [Abstract][Full Text] [Related]
57. HIV entry: are all receptors created equal?
Goldsmith MA; Doms RW
Nat Immunol; 2002 Aug; 3(8):709-10. PubMed ID: 12089511
[No Abstract] [Full Text] [Related]
58. Modification of CD4 immunoadhesin with monomethoxypoly(ethylene glycol) aldehyde via reductive alkylation.
Chamow SM; Kogan TP; Venuti M; Gadek T; Harris RJ; Peers DH; Mordenti J; Shak S; Ashkenazi A
Bioconjug Chem; 1994; 5(2):133-40. PubMed ID: 8031876
[TBL] [Abstract][Full Text] [Related]
59. Active concentration measurements of recombinant biomolecules using biosensor technology.
Zeder-Lutz G; Benito A; Van Regenmortel MH
J Mol Recognit; 1999; 12(5):300-9. PubMed ID: 10556878
[TBL] [Abstract][Full Text] [Related]
60. Molecular simulation of linear octacosane
Dai L; Chakraborty S; Wu G; Ye J; Lau YH; Ramanarayan H; Wu DT
Phys Chem Chem Phys; 2022 Mar; 24(9):5351-5359. PubMed ID: 35169819
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
